A case of thrombocytopenia associated with the use of hydroxychloroquine following open heart surgery  by Demir, Deniz et al.
A
h
D
a
b
a
A
R
R
1
A
A
K
H
C
T
1
h
d
w
a
o
u
t
p
c
t
m
(
h
2
(CASE  REPORT  –  OPEN  ACCESS
International Journal of Surgery Case Reports 5 (2014) 1282–1284
Contents lists available at ScienceDirect
International  Journal  of  Surgery  Case  Reports
j ourna l h om epage: www.caserepor ts .com
 case  of  thrombocytopenia  associated  with  the  use  of
ydroxychloroquine  following  open  heart  surgery
eniz  Demira,∗, Fatih  Öcalb, Mustafa  Abanoza, Hasan  Dermencib
S¸ anlıurfa Mehmet Akif I˙nan State Hospital, Cardiovascular Surgery Department, S¸ anlıurfa, Turkey
S¸ anlıurfa Mehmet Akif I˙nan State Hospital, Hematology Department, S¸ anlıurfa, Turkey
 r  t  i  c  l e  i  n  f  o
rticle history:
eceived 21 August 2014
eceived in revised form
0 November 2014
ccepted 10 November 2014
vailable online 20 November 2014
eywords:
ydroxychloroquine
ardiac surgery
hrombocytopenia
a  b  s  t  r  a  c  t
INTRODUCTION:  Thrombocytopenia  is  a common  problem  occurring  in patients  and drug-induced  throm-
bocytopenia  is  a signiﬁcant  cause  of thrombocytopenia.
PRESENTATION  OF  CASE:  We  present  an  unusual  case  of  thrombocytopenia  that  was  considered  to  be
associated  with  the use  of  hydroxychloroquine  in  the late  term  following  open  heart surgery.
DISCUSSION:  The  drug-induced  thrombocytopenia,  mechanical  destruction  of the platelets,  and  hemodi-
lution  are  common  causes  of  low  platelet  count.  Although  drug-induced  immune  thrombocytopenia  has
a mild  clinical  course  in  most  cases  (in this  case  it has  severe  clinical  course),  some  patients  may  experi-
ence  life-threatening  hemorrhages.  The  decision  to  discontinue  the  drug  that  is deemed  to be  responsible
from  the  drug-induced  thrombocytopenia  (DITP)  relies  on  the clinical  condition  of  the patient.  The  diag-
nosis  is  mostly  established  by discontinuation,  exclusion,  and  correlation  because  the  tests  performed  to
detect drug-dependent  antibodies  (DDAbs)  for the  diagnosis  of  DITP  are  time-consuming,  and  these  tests
are  also  not  commonly  available.  The  authors  of  the  current  study  diagnosed  DITP  by  discontinuation  of
the  drug.  We  suggest  that  the  use  of  hydroxychloroquine  could  be  severe  thrombocytopenia  occurring
after  open  heart  surgery.
CONCLUSION:  The  medication  history  must  be carefully  reviewed  in  patients  presenting  with thrombo-
cytopenia,  and  if the  medications  could  cause  thrombocytopenia  must be discontinued.
©  2014  The  Authors.  Published  by  Elsevier  Ltd. on behalf  of Surgical  Associates  Ltd.  This  is an  open
he CCaccess  article  under  t
. Introduction
Thrombocytopenia is a common problem occurring in patients
ospitalized in cardiology and cardiac surgery units. Platelet count
ecreases below 100 × 109 cells/L in 2.4–9.2% of the patients who
ere placed on abciximab, clopidogrel, or acetylsalicylic acid ther-
py after percutaneous coronary interventions.1 There is a risk
f developing thrombocytopenia in 35–65% of the patients who
ndergo cardiac surgery.2
The idiopathic thrombocytopenic purpura, drug-induced
hrombocytopenia, infections (rubella), and pseudo-thrombocyto-
enia are among the causes of thrombocytopenia.3
The current report presents a case of thrombocytopenia that was
onsidered to be associated with the use of hydroxychloroquine in
he late term following open heart surgery.∗ Corresponding author. Tel.: +90 5054571988.
E-mail addresses: denizzdr@msn.com (D. Demir), fthocal@yahoo.com (F. Öcal),
ustafaabanozdr@hotmail.com (M.  Abanoz), hasandermenci@yahoo.com
H. Dermenci).
ttp://dx.doi.org/10.1016/j.ijscr.2014.11.052
210-2612/© 2014 The Authors. Published by Elsevier Ltd. on behalf of Surgical A
http://creativecommons.org/licenses/by-nc-nd/3.0/). BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/3.0/).
2. Presentation of case
A 55-year-old male patient underwent open heart surgery dye
to coronary artery disease that remained unresponsive to medical
therapies. The patient was discharged from the hospital with full
recovery one week after coronary artery bypass graft surgery. The
platelet count at discharge after the operation was  308 × 109 cells/L.
The patient was admitted to the outpatient clinics in the Depart-
ment of Cardiovascular Surgery complaining of nose bleeding,
petechiae on the body, and ecchymosis approximately three weeks
after surgery (Fig. 1). The laboratory test revealed a platelet count
of 7 × 109 cells/L, after which the patient consulted with a hematol-
ogist. The peripheral blood smear revealed an insufﬁcient number
of platelets and the absence of atypical cells, and the patient was
then placed on steroid therapy with the pre-diagnosis of immune
thrombocytopenia. The patient underwent bone marrow aspiration
biopsy. The bone marrow aspiration biopsy was inconclusive with
the exception of slightly increased megakaryocytes. During the
follow-up of the patient, platelet count remained at low levels and
did not respond to steroid therapy. The patient’s medical history
was rechecked, and it was  revealed that the patient had been using
hydroxychloroquine for the last one week erroneously as a pain
killer, unbeknownst to the surgeons; hydroxychloroquine use was
ssociates Ltd. This is an open access article under the CC BY-NC-ND license
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The medication history must be carefully assessed in theFig. 1. Images showing petechiae on the chest of the patient.
iscontinued. The platelet counts increased over a period of several
ays, and petechia and ecchymosis on the body disappeared. The
latelet count at 1 month control visit was 300 × 109 cells/L. The
atient is under follow up for 3 months and who  was healthy in
hat time.
. Discussion
The drug-induced thrombocytopenia, mechanical destruction of
he platelets, and hemodilution are common causes of low platelet
ount encountered after open heart surgery.1
Although drug-induced immune thrombocytopenia has a
ild clinical course in most cases, in this case it was  severe
ay  depend of cross-reaction between acetyl salicylic acid and
ydroxychloroquine. Many drugs can induce the development
f immune thrombocytopenia such as antibiotics, anticonvul-
ants, and anti-inﬂammatory drugs. However, the most common
ype of drug-induced thrombocytopenia is heparin-induced
hrombocytopenia.4
Treatment varies depending on the causes of thrombocyto-
enia. For instance, steroids and intravenous immunoglobulin
IVIG) therapy are used in the treatment of immune thrombocy-
openic purpura, whereas direct thrombin inhibitors (bivalirudin,
rgatroban, lepirudin) are used in the treatment of heparin-induced
hrombocytopenia.5,6
Drug-induced thrombocytopenia occurs as a non-immune-
ediated suppression of bone marrow or immune-mediated
estruction of the platelets by speciﬁc antibodies to the drug.
hrombocytopenia is caused by myelosuppressive substances
re dose-dependent and not difﬁcult to recognize. However,
mmune-mediated thrombocytopenia is not dose-dependent andPEN  ACCESS
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the diagnosis is challenging; the reason is that these patients use
multiple medications.7
The decision to discontinue the drug that is deemed to be
responsible from the drug-induced thrombocytopenia (DITP) relies
on the clinical condition of the patient. The diagnosis is mostly
established by discontinuation, exclusion, and correlation because
the tests performed to detect drug-dependent antibodies (DDAbs)
for the diagnosis of DITP are time-consuming, and these tests are
also not commonly available.4,7
Transfusions and steroid therapy have been used in the treat-
ment of DITP; however, there is no evidence on the efﬁciency of
these therapies. The drug is eliminated from the body in a cou-
ple days in hospitalized patients, and this is followed by gradual
increase in the platelet count. Thrombocytopenia and bleeding
symptoms rarely persist for weeks. The patients with persistent
symptoms can be administered therapies such as IVIG and plasma
exchange therapy; however, the efﬁciency of these therapies has
not been clearly demonstrated.4
Hydroxychloroquine is used in the treatment of malaria,
rheumatic disorders, and systemic lupus erythematosus.8 Many
side effects have been reported associated with the use of
hydroxychloroquine. Among these side effects, there is a partic-
ular concern regarding the development of cardiomyopathy and
thrombocytopenia.9,10
The patient was  discharged with full recovery after open heart
surgery. However, the patient was  re-admitted at postoperative
3 weeks complaining of nose bleeding, petechiae, and ecchymo-
sis on the body. The platelet count was  very low upon admission.
The peripheral blood smear revealed a low platelet count and the
absence of atypical cells. The patient was  deemed to have immune
thrombocytopenia, for which he was placed on steroid therapy.
However, the patient did not respond to therapy. Meanwhile, a
more comprehensive medical history was obtained. It was  revealed
that the patient had been using hydroxychloroquine as a pain killer
outside the knowledge of the surgeons. Hydroxychloroquine use
was discontinued, and platelet count showed a gradual increase in
the following days. The platelet count was 300 × 109 cells/L at the 1
month control visit. The patient is still under follow-up at 3 months
without exhibiting any hemorrhage and other problems.
Before the patient presenting thrombocytopenia, who  was  using
100 mg  acetyl salicylic acid, antibiotic and anti-inﬂammatory drug.
During in this period, the patient’s platelet count was  within nor-
mal  range. However, after one weak, severe thrombocytopenia
was observed in the patient duo to erroneously using hydroxy-
chloroquine. In several days, after cessation of the drug platelet
levels in the patient has become the normal range. Thrombocy-
topenia was  observed while the patient was using acetylsalicylic
acid and hydroxychloroquine. Both drugs can cause this case.1,10
The diagnosis was established by discontinuation and exclusion
of hydroxychloroquine. After hydroxychloroquine was  ceased, the
patient was become health. But who still using acetylsalicylic acid
100 mg  and thrombocytopenia was  not seen in controls. Therefore
acetylsalicylic acid was  not considered as a cause of thrombocy-
topenia in this patient. Also role of 100 mg  acetyl salicylic in this
case was  considered as increasing of thrombocytopenia severity. In
order to determination drug-dependent thrombocytopenia, mostly
drug cessation and exclusion methods are used.7 Also in this case,
drug cessation was  used as exclusion method. We  believe that the
use of hydroxychloroquine is cause of thrombocytopenia.
4. Conclusiondifferential diagnosis of patients presenting with isolated throm-
bocytopenia, and the drugs that might be possibly related to
thrombocytopenia must be discontinued.
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